FDA Inspection
Mayo Clinic IRBMayo Clinic IRB – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Mayo Clinic IRB, with an inspection on April 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c40f269a-e09c-448f-a8f0-836475620433
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1013130
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Mayo Clinic IRB
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2025 | Not classified | Minneapolis District Office | |
| August 27, 2021 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| February 5, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 13, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mayo Clinic IRB
- FDA Inspection 1280600 - 2025-08-22
- FDA Inspection 1151608 - 2021-08-27
- FDA Inspection 649154 - 2010-02-05
- FDA Inspection 576544 - 2009-04-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.